Steve Goetz

Steve currently serves as Chief Technology Officer at Motif Neurotech, where he leads all aspects of R&D for the Motif XCS System for Treatment Resistant Depression. Before joining Motif, Steve held leadership and engineering positions of increasing responsibility during his 26-year career at Medtronic. Most recently, he served as Vice President of Technology and Platform Innovation in the Neuromodulation Operating Unit, driving new therapeutic opportunities in bioelectronic medicine and defining major new implantable device architectures. Prior to this, Steve served in a variety of roles in and around Medtronic’s Brain Modulation Business, including time as the Chief Engineer for deep brain stimulation and roles leading technology strategy and business development, work for which he was recognized as a Bakken Fellow, Medtronic’s most prestigious technical award. Steve holds over 160 patents and has contributed to multiple publications in the field. He holds a BSEE from Rose-Hulman Institute of Technology and an MSEE from the University of Minnesota.